71 related articles for article (PubMed ID: 2213040)
1. Botulinum toxin treatment in spasmodic torticollis.
Blackie JD; Lees AJ
J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):640-3. PubMed ID: 2213040
[TBL] [Abstract][Full Text] [Related]
2. Reliability of DNMSQuest as a Screening Tool for Mood Disorders in Cervical Dystonia.
Rafee S; Ndukwe I; O'Riordan S; Hutchinson M
Mov Disord Clin Pract; 2021 Aug; 8(6):925-931. PubMed ID: 34405100
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A therapy for cervical dystonia.
Rodrigues FB; Duarte GS; Marques RE; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003633. PubMed ID: 33180963
[TBL] [Abstract][Full Text] [Related]
4. Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study.
Kutschenko A; Klietz M; Paracka L; Kollewe K; Schulte-Sutum A; Janssen T; Schrader C; Wegner F; Dressler D
J Neural Transm (Vienna); 2020 Aug; 127(8):1161-1165. PubMed ID: 32588245
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A therapy for cervical dystonia.
Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
[TBL] [Abstract][Full Text] [Related]
6. Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives.
de Tommaso M; Arendt-Nielsen L; Defrin R; Kunz M; Pickering G; Valeriani M
Behav Neurol; 2016; 2016():7576292. PubMed ID: 27313396
[TBL] [Abstract][Full Text] [Related]
7. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
Camargo CH; Cattai L; Teive HA
Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
[TBL] [Abstract][Full Text] [Related]
8. Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.
Jost WH; Hefter H; Stenner A; Reichel G
J Neural Transm (Vienna); 2013 Mar; 120(3):487-96. PubMed ID: 22899277
[TBL] [Abstract][Full Text] [Related]
9. Current and future medical treatment in primary dystonia.
Delnooz CC; van de Warrenburg BP
Ther Adv Neurol Disord; 2012 Jul; 5(4):221-40. PubMed ID: 22783371
[TBL] [Abstract][Full Text] [Related]
10. Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials.
Tinazzi M; Valeriani M; Squintani G; Corrà F; Recchia S; Defazio G; Berardelli A
J Neurol; 2012 Oct; 259(10):2060-6. PubMed ID: 22349875
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin Deaths: What is the Fact?
Omprakash Hm ; Rajendran Sc
J Cutan Aesthet Surg; 2008 Jul; 1(2):95-7. PubMed ID: 20300354
[No Abstract] [Full Text] [Related]
12. Botulinum toxin type A in the treatment of patients with cervical dystonia.
Brashear A
Biologics; 2009; 3():1-7. PubMed ID: 19707390
[TBL] [Abstract][Full Text] [Related]
13. Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.
Schulte-Mattler WJ
CNS Drugs; 2008; 22(9):725-38. PubMed ID: 18698873
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin in the management of dystonia.
Cardona-Garcia OD; Higgins DS; Molho ES
Curr Treat Options Neurol; 2007 May; 9(3):224-33. PubMed ID: 17445500
[TBL] [Abstract][Full Text] [Related]
15. Preswallowing dystonia.
Ertekin C; Aydogdu I; Ozdemirkiran T; Seçil Y; Bor S
Dysphagia; 2005; 20(1):15-8. PubMed ID: 15886962
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for cerebral palsy; where are we now?
Morton RE; Hankinson J; Nicholson J
Arch Dis Child; 2004 Dec; 89(12):1133-7. PubMed ID: 15557051
[TBL] [Abstract][Full Text] [Related]
17. Oropharyngeal swallowing in craniocervical dystonia.
Ertekin C; Aydogdu I; Seçil Y; Kiylioglu N; Tarlaci S; Ozdemirkiran T
J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):406-11. PubMed ID: 12235309
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological options for the treatment of Tourette's disorder.
Jiménez-Jiménez FJ; García-Ruiz PJ
Drugs; 2001; 61(15):2207-20. PubMed ID: 11772131
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
Hyman N; Barnes M; Bhakta B; Cozens A; Bakheit M; Kreczy-Kleedorfer B; Poewe W; Wissel J; Bain P; Glickman S; Sayer A; Richardson A; Dott C
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):707-12. PubMed ID: 10811692
[TBL] [Abstract][Full Text] [Related]
20. Costs of treating dystonias and hemifacial spasm with botulinum toxin A.
Dodel RC; Kirchner A; Koehne-Volland R; Künig G; Ceballos-Baumann A; Naumann M; Brashear A; Richter HP; Szucs TD; Oertel WH
Pharmacoeconomics; 1997 Dec; 12(6):695-706. PubMed ID: 10175981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
